Novavax NVX-CoV2373 Clinical Trial Data 2022

Comprehensive clinical data appendix for Novavax's NVX-CoV2373 COVID-19 vaccine candidate, covering Phase 1, 2, and 3 trial results from PREVENT-19 studies across the U.S., Mexico, UK, South Africa, and Australia. Includes safety, efficacy, and development information for primary, booster, and pediatric vaccine indications.